Frequency of Tuberculosis in Psoriasis Patients

Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis Vulgaris Actinomycetales Infections Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Infections Mycobacterium Infections Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases Tuberculosis

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bezmialem Vakif University Hospital

Istanbul, Turkey (Türkiye)

About this study

Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center. TNF inhibitor therapy may increase the risk for tuberculosis infection. According to medical data in our hospital in last 15 years, tuberculosis rate of psoriasis patients receiving etanercept, adalimumab and infliximab will be compared.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

psoriasis patients receiving TNF inhibitor therapy

Exclusion criteria

patients without TNF inhibitor therapy

Treatment and study plan

Primary outcomes

tuberculosis rate

Time frame: patients from June 2007 to January 2023, up to 15 years

number of patients with tuberculosis infection after receiving TNF inhibitor therapy

Sponsors and collaborators

Lead sponsor

Bezmialem Vakif University

Other

Registry information

Official study title

Frequency of Tuberculosis in Psoriasis Patients Using Anti-TNF Therapy During 15 Years of Follow-up.

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Aug 21, 2024
Registry last updated: Aug 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed